Insmed Stock Forecast

Insmed stock downgraded from Strong Buy Candidate to Buy Candidate after Monday trading session.
(Updated on Jun 17, 2024)

INSM Signals & Forecast

Mostly positive signals in the chart today. The Insmed stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $61.50 and $39.28. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Friday, May 24, 2024, and so far it has risen 194.09%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.

Support, Risk & Stop-loss for Insmed stock

On the downside, the stock finds support just below today's level from accumulated volume at $56.98 and $55.05. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Insmed finds support just below today's level at $56.98. If this is broken, then the next support from accumulated volume will be at $55.05 and $53.55.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $3.32 between high and low, or 5.38%. For the last week, the stock has had daily average volatility of 5.73%.

The Insmed stock is overbought on RSI14 and lies in the upper part of the trend. Normally this may pose a good selling opportunity for the short-term trader, but some stocks may go long and hard while being overbought. Regardless, the high RSI together with the trend position increases the risk and higher daily movements (volatility) should be expected. A correction down in the nearby future seems very likely and it is of great importance that the stock manages to break the trend before that occurs.

Our recommended stop-loss: $62.90 (-2.78%) (This stock has very high daily movements and this gives very high risk. The RSI14 is 86 and this increases the risk substantially. There is a buy signal from a pivot bottom found 26 days ago.)

Trading Expectations (INSM) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect Insmed to open at $63.78, and during the day (based on 14 day Average True Range), to move between $61.34 and $68.06, which gives a possible trading interval of +/-$3.36 (+/-5.19%) up or down from last closing price. If Insmed takes out the full calculated possible swing range there will be an estimated 10.37% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $56.98, some $7.72 (11.93%) from the current price of $64.70, our system finds the risk reward attractive.

Is Insmed stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Insmed stock to perform well in the short-term. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Buy candidate.

Current score: 4.463 Buy Candidate Downgraded

Predicted Opening Price for Insmed of Tuesday, June 18, 2024

The predicted opening price is based on yesterday's movements between high, low, and closing price.